1. All Products
  2. TRANEXAMIC acid, 100mg/ml, 5ml amp.
Public Pricelist

TRANEXAMIC acid, 100mg/ml, 5ml amp.

https://medicalguidelines.msf.org/en/node/937
https://unicat.msf.org/cat/product/11816
STD DINJTRAN5A-

Valid Article

Former Code(s): -X DINJZBD0094 DINJZYN1014 DINJOCBZLB0001 DINJZBE0044
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
10.2 - Medicines affecting coagulation
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
22.5 - Other medicines administered to the mother
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
B02AA02
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

TRANEXAMIC acid

Therapeutic Action

Haemostatic with antifibrinolytic action

Indications

Postpartum haemorrhage

Massive abnormal uterine bleeding unrelated to pregnancy

Trauma-associated haemorrhage

Instructions for use

Must be given as slow IV injection or IV ninfusion in 0.9% NaCl or 5% dextrose.

Precautions for Use

Do not administer by IM route.

Storage

Below 25ºC